Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > i wonder what has happened to the FDA APPLICATION

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Feb 15, 2022 1:13pm

111 Views

Post# 34430656

RE:RE:RE:i wonder what has happened to the FDA APPLICATION

It is sad to see this dipping to this level. Tbp is not doing a great job in investors relationship. There were really no material update since Nov last year. It always shorts to take control and it is now at all time low ahead of major milestones. They really need to improve on the ir side of things.

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo